Skip to content

A Randomized Controlled Trial of Acupuncture for Loss of Appetite in Patients with Advanced Lung Cancer

Acupuncture Combined With PD-1/PD-L1 Inhibitors for Advanced Lung Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001225
Enrollment
Unknown
Registered
2025-06-19
Start date
2025-07-10
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Sponsors

Guang'anmen Hospital Chinese Academy of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Age 18-75 years; 2) ECOG/PS score of grade 0-1 and expected survival = 3 months; 3) Non-small cell lung cancer AJCC lung cancer staging of stage IIIB-IV or small cell lung cancer staging of extensive stage; 4) Those with low or negative PD-L1 expression (TPS 1cm) or lymph node short diameter 1.5 cm; 9) Signed an informed consent form to voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: 1) Combined with other primary malignant tumors; 2) Those who have contraindications to immunotherapy after basic evaluation of immunotherapy pre-treatment; 3) Those who have autoimmune system diseases or need long-term treatment with systemic steroids or immunosuppressants; 3) Those who have autoimmune system diseases or need long-term treatment with systemic steroids or immunosuppressants; 4) Those who are combined with serious and uncontrolled primary diseases of the heart cerebrovascular system liver kidney and hematopoietic system; 5) Those with metal allergy or severe fear of needles; 6) Those who are pregnant or breastfeeding; 7) Those with mental disorders or intellectual or speech impairment that prevents them from cooperating to complete the assessment; 8) Those with active severe infectious or inflammatory diseases; 9) Those who have received acupuncture treatment or other clinical trials within 1 month prior to randomization; 10) Those who are unable to take food by mouth; 11) Persons with concomitant illnesses that in the judgment of the investigator seriously jeopardize the safety of the participant or interfere with the completion of the study or who are deemed to have other reasons for being unsuitable for enrollment.

Design outcomes

Primary

MeasureTime frame
Functional Assessment of Anorexia/Cachexia Therapy - Anorexia/Cachexia Subscale;Visual Analog Score for loss of appetite;

Secondary

MeasureTime frame
Patient Health Questionnaire-9;Generalized Anxiety Disorder-7;Lung Cancer Symptom Scale;Eastern Cooperative Oncology Group Performance Status;Insomnia Severity Index;Adverse Event;Disease Control Rate;weight;Objective Response Rate;

Countries

China

Contacts

Public ContactJiarong Fan

Guang'anmen Hospital Chinese Academy of Traditional Chinese Medicine

fjrr1115@163.com18811189057

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026